Increased CD4⁺CXCR5⁺T follicular helper cells in diabetic nephropathy

References

• Xie, Y. S., and X. M. Chen. 2008. Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China. Am. J. Nephrol. 28: 1–7
   PubMed Web of Science ®Google Scholar
• Packham, D. K., T. P. Alves, J. P. Dwyer, et al. 2012. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (diabetes mellitus treatment for renal insufficiency consortium) database. Am. J. Kidney Dis. 59: 75–83
   PubMed Web of Science ®Google Scholar
• Elmarakby, A. A., and J. C. Sullivan. 2012. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc. Ther. 30: 49–59
   PubMed Web of Science ®Google Scholar
• Avarro-González, J. F., and C. Mora-Fernández. 2008. The role of inflammatory cytokines in diabetic nephropathy. J. Am. Soc. Nephrol. 19: 433–442
   PubMed Web of Science ®Google Scholar
• Aballa, M., and M. K. Farag. 2013. Predictors of diabetic nephropathy. Eur. J. Med. 8: 287–296
   Web of Science ®Google Scholar
• Lopez-Parra, V., B. Mallavia, J. Egido, et al. 2012. Immunoinflammation in diabetic nephropathy: molecular mechanisms and therapeutic options. In Chan JSD; Diabetic Nephropathy. Rijeka, Croatia: InTech, 127–146
   Google Scholar
• Sanchez, A. P., and K. Sharma. 2009. Transcription factors in the pathogenesis of diabetic nephropathy. Expert Rev. Mol. Med. 11: e13
   PubMed Web of Science ®Google Scholar
• Navarro-González, J. F., A. Jarque, M. Muros, et al. 2009. Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy. Cytokine Growth Factor Rev. 20: 165–173
   PubMed Web of Science ®Google Scholar
• King, C., S. G. Tangye., and C. R. Mackay. 2008. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 26: 741–766
   PubMed Web of Science ®Google Scholar
• Crotty, S. 2011. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29: 621–63
   PubMed Web of Science ®Google Scholar
• Aurent, C., N. Fazilleau, and P. Brousset. 2010. A novel subset of T-helper cells: follicular T-helper cells and their markers. Haematologica. 95: 356–358
   PubMed Web of Science ®Google Scholar
• Linterman, M. A., and C. G. Vinuesa. 2010. Signals that influence T follicular helper cell differentiation and function. Semin. Immunopathol. 32: 183–196
   PubMed Web of Science ®Google Scholar
• Zhang, N., P. W. Zhao, Y. F. Jiang, et al. 2014. A higher frequency of CD4+CXCR5+ T follicular helper cells in adult patients with minimal change disease. Biomed. Res. Int. 2014: 1–13
   Google Scholar
• Zhang, L., Y. Wang, X. Shi, et al. 2014. A higher frequency of CD4+CXCR5+ T follicular helper cells in patients with newly diagnosed IgA nephropathy. Immunol. Lett. 158: 101–108
   PubMed Web of Science ®Google Scholar
• Cannons, J. L., K. L. Lu, and P. L. Schwartzberg. 2013. T follicular helper cell diversity and plasticity. Trends Immunol. 34: 200–207
   PubMed Web of Science ®Google Scholar
• Morita, R., N. Schmitt, S. E. Bentebibel, et al. 2011. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 34: 108–121
   PubMed Web of Science ®Google Scholar
• Tangye, S., C. S. Ma, R. Brik, and E. K. Deenick. 2013. The good, the bad and the ugly – Tfh cells in human health and disease. Nat. Rev. Immunol. 13: 412–426
   PubMed Web of Science ®Google Scholar
• Matsuo, S., E. Imai, M. Horio, et al. 2009. Revised equations for estimated GFR from serum creatinine in Japan. Am. J. Kidney Dis. 53: 982–992
   PubMed Web of Science ®Google Scholar
• Jiang, Y., Z. Ma, G. Xin, et al. 2010. Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil. Mediators Inflamm. 2010: 143026
   PubMed Web of Science ®Google Scholar
• Morgan, E., R. Varro, H. Sepulveda, et al. 2004. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin. Immunol. 110: 252–266
   PubMed Web of Science ®Google Scholar
• Tárnok, A., J. Hambsch, R. Chen, et al. 2003. Cytometric bead array to measure six cytokines in twenty-five microliters of serum. Clin. Chem. 49: 1000–1002
   PubMed Web of Science ®Google Scholar
• Duran-Salgado, M. B., and A. F. Rubio-Guerra. 2014. Diabetic nephropathy and inflammation. World J. Diabetes. 5: 393–398
   PubMedGoogle Scholar
• Ahmad, J. 2015. Management of diabetic nephropathy: recent progress and future perspective. Diabetes Metab. Syndr. 9: 343–358
   PubMed Web of Science ®Google Scholar
• Earle, K., and G. C. Viberti. 1994. Familial, hemodynamic and metabolic factors in the predisposition to diabetic kidney disease. Kidney Int. 45: 434–437
   PubMed Web of Science ®Google Scholar
• Ayodele, O. E., C. O. Alebiosu, and B. L. Salako. 2004. Diabetic nephropathy-a review of the natural history, burden, risk factors and treatment. J. Natl. Med. Assoc. 96: 1445–54
   PubMed Web of Science ®Google Scholar
• Shane T., and B. Grey. 2012. B cells as effectors and regulators of autoimmunity. Autoimmunity. 45: 377–387
   PubMed Web of Science ®Google Scholar
• Fleiner, H. F., M. Radtke, and L. Ryan. 2014. Circulating immune mediators are closely linked in adult-onset type 1 diabetes as well as in non-diabetic subjects. Autoimmunity. 47: 530–537
   PubMed Web of Science ®Google Scholar
• Breitfeld, D., L. Ohl, E. Kremmer, et al. 2000. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192: 1545–1552
   PubMed Web of Science ®Google Scholar
• Schaerli, P., K. Willimann, A. B. Lang, et al. 2000. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192: 1553–1562
   PubMed Web of Science ®Google Scholar
• Good-Jacobson, K. L., C. G. Szumilas, L. Chen, et al. 2010. PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat. Immunol. 11: 535–542
   PubMed Web of Science ®Google Scholar
• Allman, D., A. Jain, A. Dent, et al. 1996. BCL-6 expression during B-cell activation. Blood. 87: 5257–5268
   PubMed Web of Science ®Google Scholar
• Cattoretti, G., C. C. Chang, K. Cechova, et al. 1995. BCL-6 protein is expressed in germinal-center B cells. Blood. 86: 45–53
   PubMed Web of Science ®Google Scholar
• Onizuka, T., M. Moriyama, T. Yamochi, et al. 1995. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood. 86: 28–37
   PubMed Web of Science ®Google Scholar
• Walker, L. S. 1999. Compromised Ox40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers. J. Exp. Med. 190: 1115–1122
   PubMed Web of Science ®Google Scholar
• Heissmeyer, V., and K. U. Vogel. 2013. Molecular control of Tfh-cell differentiation by Roquin family proteins. Immunol. Rev. 253: 273–289
   PubMed Web of Science ®Google Scholar
• Tellier, J., and S. L. Nutt. 2013. The unique features of follicular T cell subsets. Cell. Mol. Life sci. 70: 4771–4784
   PubMed Web of Science ®Google Scholar
• Chang, P. P., P. Barral, J. Fitch, et al. 2012. Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat. Immunol. 13: 35–43
   Web of Science ®Google Scholar
• Yazici, M. U., D. Orhan, G. Kale, et al. 2014. Studying IFN-gamma, IL-17 and FOXP3 in pediatric lupus nephritis. Pediatr. Nephrol. 29: 853–862
   PubMed Web of Science ®Google Scholar
• Ma, J., J. Yu, X. Tao, et al. 2010, The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients. Clin. Rheumatol. 29: 1251–1258
   PubMed Web of Science ®Google Scholar
• LeBien, T. W., and T. F. Tedder. 2008. B lymphocytes: how they develop and function. Blood. 112: 1570–1580
   PubMed Web of Science ®Google Scholar
• Ferrari, S., S. Giliani, A. Insalaco, et al. 2001. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc. Natl. Acad. Sci. USA. 98: 12614–12619
   PubMed Web of Science ®Google Scholar
• Korthauer, U., D. Graf, H. W. Mages, et al. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature. 361: 539–541
   PubMed Web of Science ®Google Scholar
• Grimbacher, B., A. Hutloff, M. Schlesier, et al. 2003. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat. Immunol. 4: 261–8
   PubMed Web of Science ®Google Scholar
• Johnston, R. J., A. C. Poholek, D. DiToro, et al. 2009. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science. 325: 1006–1010
   PubMed Web of Science ®Google Scholar